NCT06236282View on ClinicalTrials.gov

ArtiSential® for Rectal Cancer Surgery

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

May 1, 2012

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2023

Conditions
Rectal Cancer
Interventions
DEVICE

ArtiSential®

Articulated laparoscopic device made by Livsmed Co, South Korea.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT06236282 - ArtiSential® for Rectal Cancer Surgery | Biotech Hunter | Biotech Hunter